The inhibitory effect of 163 was regulated by the inactivation of the NF-κB, MAPK, and TLR4/MyD88 signaling pathways, indicating that 163 is potential anti-inflammatory candidate for the treatment of neurodegenerative diseases [72] (Figure 8). The gene discussed is TLR4; the disease is neurodegenerative disease.